DK1052975T3 - Propofolsammensætning indeholdende sulfit - Google Patents

Propofolsammensætning indeholdende sulfit

Info

Publication number
DK1052975T3
DK1052975T3 DK99905958T DK99905958T DK1052975T3 DK 1052975 T3 DK1052975 T3 DK 1052975T3 DK 99905958 T DK99905958 T DK 99905958T DK 99905958 T DK99905958 T DK 99905958T DK 1052975 T3 DK1052975 T3 DK 1052975T3
Authority
DK
Denmark
Prior art keywords
composition containing
containing sulfite
propofol composition
propofol
sulfite
Prior art date
Application number
DK99905958T
Other languages
Danish (da)
English (en)
Inventor
Dorla Mirejovsky
Liananingsih Tanudarma
Dilip Ashtekar
Original Assignee
Sicor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sicor Inc filed Critical Sicor Inc
Application granted granted Critical
Publication of DK1052975T3 publication Critical patent/DK1052975T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Anesthesiology (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK99905958T 1998-02-10 1999-02-10 Propofolsammensætning indeholdende sulfit DK1052975T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2167198A 1998-02-10 1998-02-10
PCT/US1999/003036 WO1999039696A1 (en) 1998-02-10 1999-02-10 Propofol composition containing sulfite

Publications (1)

Publication Number Publication Date
DK1052975T3 true DK1052975T3 (da) 2007-12-27

Family

ID=21805509

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99905958T DK1052975T3 (da) 1998-02-10 1999-02-10 Propofolsammensætning indeholdende sulfit

Country Status (17)

Country Link
US (2) US6147122A (de)
EP (1) EP1052975B1 (de)
JP (1) JP2002502811A (de)
AR (1) AR015516A1 (de)
AT (1) ATE370726T1 (de)
AU (1) AU750040B2 (de)
BR (1) BR9907832A (de)
CA (1) CA2319810C (de)
CO (1) CO4810371A1 (de)
CY (1) CY1106970T1 (de)
DE (1) DE69936911T2 (de)
DK (1) DK1052975T3 (de)
ES (1) ES2292233T3 (de)
NZ (1) NZ505948A (de)
PE (1) PE20000264A1 (de)
PT (1) PT1052975E (de)
WO (1) WO1999039696A1 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6749868B1 (en) 1993-02-22 2004-06-15 American Bioscience, Inc. Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
AU2001266896B2 (en) 2000-06-16 2006-04-06 Jagotec Ag Improved injectable dispersions of propofol
IN188917B (de) * 2000-12-07 2002-11-23 Bharat Surums & Vaccines Ltd
WO2002051411A1 (fr) * 2000-12-22 2002-07-04 Yamanouchi Pharmaceutical Co., Ltd. Injections de famotidine
JP4127757B2 (ja) * 2001-08-21 2008-07-30 株式会社エヌ・ティ・ティ・ドコモ 無線通信システム、通信端末装置、及びバースト信号送信方法
ATE522498T1 (de) * 2002-01-25 2011-09-15 Theravance Inc Sedative hypnotisch wirkende verbindungen mit kurzer wirkungsdauer zur anaesthesie und sedierung
MXPA04009703A (es) * 2002-04-08 2004-12-13 Guilford Pharm Inc Composiciones farmaceuticas que contienen promedicamentos solubles en agua de propofol y metodoss para administrar los mismos.
JP4290381B2 (ja) * 2002-04-11 2009-07-01 学校法人 聖マリアンナ医科大学 ピリドンカルボン酸化合物含有エマルション
CN1708270A (zh) * 2002-10-29 2005-12-14 转化医药公司 丙泊酚与半胱氨酸
SI1585548T1 (sl) 2002-12-09 2018-11-30 Abraxis Bioscience, Llc Sestave in metode odmerjanja farmakoloških sredstev
US20040225022A1 (en) * 2003-05-09 2004-11-11 Desai Neil P. Propofol formulation containing reduced oil and surfactants
US8476010B2 (en) 2003-07-10 2013-07-02 App Pharmaceuticals Llc Propofol formulations with non-reactive container closures
US7790766B2 (en) * 2003-07-23 2010-09-07 Theravance, Inc. Pharmaceutical compositions of short-acting sedative hypnotic agent
US8546453B2 (en) * 2003-08-14 2013-10-01 Rensheng Zhang Propofol compositions and methods for reducing pain associated with propofol injection
WO2005044229A1 (en) * 2003-11-05 2005-05-19 The Australian National University Dispersions and methods of preparing them
EP1711163A2 (de) * 2004-02-05 2006-10-18 Baxter International Inc. Unter verwendung von selbststabilisierenden mitteln hergestellte dispersionen
US8383687B2 (en) 2004-02-13 2013-02-26 Medds, Inc. Microemulsion preparation of high concentration propofol for anesthetic uses
EP1799266A2 (de) * 2004-09-13 2007-06-27 Bharat Serums & Vaccines Ltd. Stabile emulsionszusammensetzungen für die intravenöse verabreichung mit antimikrobiell erhaltender wirksamkeit
US8557861B2 (en) * 2004-09-28 2013-10-15 Mast Therapeutics, Inc. Low oil emulsion compositions for delivering taxoids and other insoluble drugs
EP1850829A4 (de) * 2005-02-03 2012-12-26 Taro Pharmaceuticals Usa Inc Neue propofolzusammensetzung mit ascorbinsäure oder pharmazeutisch nutzbaren salzen davon
CN100358513C (zh) * 2005-04-07 2008-01-02 常州市第四制药厂有限公司 一种丙泊酚注射液的制备工艺
WO2006128088A1 (en) * 2005-05-27 2006-11-30 Sandhya Goyal Novel propofol composition comprising a pharmaceutically acceptable salt of formaldehyde sulfoxylate
ATE420625T1 (de) 2005-08-05 2009-01-15 Bharat Serums & Vaccines Ltd Intravenöse propofol-emulsionszusammensetzungen mit konservierendem effekt
US20090203794A1 (en) * 2005-08-12 2009-08-13 Gautam Vinod Daftary Aqueous Anaesthetic Composition Comprising Propofol
CN101291658B (zh) 2005-08-31 2014-04-16 阿布拉科斯生物科学有限公司 用于制备稳定性增加的水难溶性药物的组合物和方法
RU2433818C2 (ru) 2005-08-31 2011-11-20 АБРАКСИС БАЙОСАЙЕНС, ЭлЭлСи Композиции, включающие слаборастворимые в воде фармацевтические вещества и противомикробные вещества
US20070092464A1 (en) * 2005-10-25 2007-04-26 Duff Rocky J Betadine neutralizer
TWI376239B (en) * 2006-02-01 2012-11-11 Andrew Xian Chen Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
US9132090B2 (en) 2009-01-13 2015-09-15 Chetan Majmudar Propofol based anesthetic with preservative
US8658676B2 (en) 2010-10-12 2014-02-25 The Medicines Company Clevidipine emulsion formulations containing antimicrobial agents
BR112013008601B1 (pt) * 2010-10-12 2020-03-31 Chiesi Farmaceutici S.P.A. Formulações de emulsão de clevidipina contendo agentes antimicrobianos
JP6247685B2 (ja) 2012-05-16 2017-12-13 メワ・シン 実質的に水不溶性の薬物の送達のための医薬組成物
CN104622806B (zh) * 2015-02-04 2018-03-16 北京蓝丹医药科技有限公司 一种丙泮尼地药物组合物及其制备方法
WO2017017693A1 (en) 2015-07-24 2017-02-02 Neon Laboratories Limited Stabilized injectable emulsion of propofol and ketamine
WO2017031261A1 (en) 2015-08-20 2017-02-23 Mewa Singh Polyphenolic polymer to make water-insoluble molecules become water-soluble
US11992483B2 (en) 2021-03-31 2024-05-28 Cali Biosciences Us, Llc Emulsions for local anesthetics

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1472793A (en) * 1974-03-28 1977-05-04 Ici Ltd Pharmaceutical compositions
US4798846A (en) * 1974-03-28 1989-01-17 Imperial Chemical Industries Plc Pharmaceutical compositions
DE69227561T2 (de) * 1991-08-21 1999-06-02 Eisai Co Ltd Kondensierte Pyrimidinderivate als Antitumorverbindungen
GB9405593D0 (en) * 1994-03-22 1994-05-11 Zeneca Ltd Pharmaceutical compositions
US5731356A (en) * 1994-03-22 1998-03-24 Zeneca Limited Pharmaceutical compositions of propofol and edetate
AU6708096A (en) * 1995-09-18 1997-04-09 Vesifact Ag Propofol nanodispersions
US5637625A (en) * 1996-03-19 1997-06-10 Research Triangle Pharmaceuticals Ltd. Propofol microdroplet formulations

Also Published As

Publication number Publication date
JP2002502811A (ja) 2002-01-29
EP1052975A1 (de) 2000-11-22
AR015516A1 (es) 2001-05-02
US6147122A (en) 2000-11-14
NZ505948A (en) 2003-10-31
CY1106970T1 (el) 2012-09-26
ES2292233T3 (es) 2008-03-01
CA2319810A1 (en) 1999-08-12
DE69936911D1 (de) 2007-10-04
CA2319810C (en) 2008-12-23
CO4810371A1 (es) 1999-06-30
US6469069B1 (en) 2002-10-22
EP1052975B1 (de) 2007-08-22
PT1052975E (pt) 2007-10-29
AU750040B2 (en) 2002-07-11
WO1999039696A1 (en) 1999-08-12
BR9907832A (pt) 2000-10-31
AU2599199A (en) 1999-08-23
DE69936911T2 (de) 2008-05-15
ATE370726T1 (de) 2007-09-15
PE20000264A1 (es) 2000-04-11

Similar Documents

Publication Publication Date Title
DK1052975T3 (da) Propofolsammensætning indeholdende sulfit
ATE300601T1 (de) Bleichmittelzusammensetzungen
DE69832516D1 (de) Isoflavon-enthaltende zusammensetzungen
DE69830160D1 (de) Bleichmittelzusammensetzungen
DE69836106D1 (de) Stanolester enthaltende Zusammensetzungen
ID26186A (id) Komposisi sampo
ID28694A (id) Komposisi sampo
ATE417099T1 (de) Bleichmittelzusammensetzungen enthaltend mehrfach substituierte protease varianten
ID29430A (id) Komposisi herbisida
DE69908252D1 (de) Geruchsmaskierte Dimethylsulfid-Zusammensetzung
BR9813566B1 (pt) composição biocida estabilizada contendo compostos de halopropinila.
DE69841155D1 (de) Emulsionzusammensetzung
DE69942892D1 (de) Gaserzeugende zusammensetzung
DE69928862D1 (de) Zusammensetzung
DE69936208D1 (de) Modifiziermittel enthaltende zusammensetzung
DE69908845D1 (de) Fotoresistzusammensetzung
ATE302839T1 (de) Bleichungzusammensetzungen
DE69809175T2 (de) Flavanon-enthaltende Zusammensetzungen
DE69800897T2 (de) Chemisch verstärkte Positiv-Resistzusammensetzung
DE59712835D1 (de) Stabilisierte monomerenzusammensetzung
DE69915683D1 (de) Emulsionszusammensetzungen
DE69806145D1 (de) 3-alkylcycloalkanole enthaltende reichstoffkompositionen
ID22406A (id) Komposisi-komposisi umpan racun
ITMI991225A0 (it) Composizioni stabilizzate con diossopiperazinil-derivati
ID26295A (id) Komposisi keras-ultraviolet